Phase III Study of Coagulation FVIIa (Recombinant) in Congenital Hemophilia A or B Patients With Inhibitors

Clinical trial NCT02020369 · COMPLETED

Trial details

NCT number: NCT02020369
Sponsor: rEVO Biologics
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Hemophilia A With Inhibitors Hemophilia B With Inhibitors

Start date: 2014-04-01
Primary completion: 2015-07-01
Enrollment: 27

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.